Where does KPC Pharmaceuticals, Inc rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), KPC Pharmaceuticals, Inc ranks #48,221 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does KPC Pharmaceuticals, Inc hold?

KPC Pharmaceuticals, Inc holds 5 US utility patents granted between 2017 and 2025, spanning 8 technology areas.

What is KPC Pharmaceuticals, Inc's Innovation Score?

KPC Pharmaceuticals, Inc has an Innovation Score of 37.9 out of 100 (top 42% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does KPC Pharmaceuticals, Inc focus on?

KPC Pharmaceuticals, Inc's top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 5 patents, ranking #3,434 of 6,058 assignees active in that subclass. Grants appear in 8 CPC subclasses total.

Is KPC Pharmaceuticals, Inc's patent grant rate increasing or decreasing?

KPC Pharmaceuticals, Inc's recent grant velocity is +0% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for KPC Pharmaceuticals, Inc's patents?

KPC Pharmaceuticals, Inc's patents average 14.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the KPC Pharmaceuticals, Inc patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

KPC Pharmaceuticals, Inc

USPTO PatentsView assignee record - 5 granted patents across 8 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, KPC ranks #48,221 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 8 technology areas.

#48,221
of 49,997 US assignees by volume: Top 42%
by Innovation Score (37.9/100): 14.0
avg claims per patent: +0%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R48221 · Foreign Corporation #48,221 · 5 grants

GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-FLAT · BOOK-FULL

GRANTS-MICRO 5 grants
BOTTOM-DECILE #48,221/49,997
PHOTO-FINISH Korea (CENTER FOR…
CPC-NARROW A61P · 8 areas
INNOV-THIN 37.9/100
CLAIMS-RICH 14.0 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-FLAT +0% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Korea (CENTER FOR Disease Control AND PREVENTION) (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How KPC’s 37.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 6.2 pts (16%) Velocity 13.3 pts (35%) Breadth 10.0 pts (26%) Claim depth 8.4 pts (22%)

Qualcomm Incorporated · highest

85
CUE Health · near

38
JAC Products · near

38
KPC Pharmaceuticals · this assignee

38
Novadaq ULC · near

38
Osiris Therapeutics · near

38
3D Lighting… · lowest

7

What this shows KPC's Innovation Score is 37.9/100 (top 42% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for KPC?

Each dot is one of KPC’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). KPC’s own 14.0 claims/patent is ABOVE the 8.8 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

KPC vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where KPC's grants concentrate

KPC Pharmaceuticals, Inc is a focused PatentsView assignee: 8 CPC subclasses with 100% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). By volume, KPC sits between Korea (CENTER FOR Disease Control AND PREVENTION) and Krdc Ltd..

KPC's three-year grant acceleration

KPC Pharmaceuticals, Inc shows 2 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Korea (Center FOR…

5
Koros Technology…

5
Korro BIO

5
Kotobuki Tsushou

5
Kragsac

5
Krallmann Kunstst…

5
Kraussmaffei Extr…

5
Krdc

5
KPC Pharmaceutica… ◀

5

What this shows KPC holds 5 patents at rank #48,138, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near KPC

By rank, the assignees closest to #48,138 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in KPC's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for KPC, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), KPC ranks #3,434 of 6,058 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (38 here).

Osiris Therapeutics, Inc. 38 CUE Health Inc. 38 Novadaq Technologies ULC 38 JAC Products, Inc. 38

KPC's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

38 Top 42% higher than 58% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

KPC Pharmaceuticals, Inc patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	1	20.0%
2019	1	20.0%
2022	1	20.0%
2023	1	20.0%
2025partial year	1	20.0%

Which technologies does KPC Pharmaceuticals, Inc patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 5

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 3

C07D - Heterocyclic Compounds 2

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 1

B01D - Separation 1

C08G - Macromolecular Compounds Obtained Otherwise Than BY Reactions Only Involving Unsaturated Carbon-to-carbon Bonds 1

C08L - Compositions OF Macromolecular Compounds 1

Y02A - Technologies FOR Adaptation TO Climate Change 1

Top 8 of 8 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

KPC Pharmaceuticals, Inc's patent record in context - here's where to go next.

KPC Pharmaceuticals, Inc's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 100% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #48,221 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare KPC Pharmaceuticals, Inc against Korea (CENTER FOR Disease Control AND PREVENTION), an assignee filing at a similar volume. Compare portfolios
Innovation Score of 37.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.